Thrombolysis induced by intravenous administration of plasminogen activator in magnetoliposomes: dual targeting by magnetic and thermal manipulation

Nanomedicine. 2019 Aug:20:101992. doi: 10.1016/j.nano.2019.03.014. Epub 2019 Apr 11.

Abstract

In previously published studies, intra-arterial (i.a.), but not intravenous (i.v.) delivery of recombinant tissue-type plasminogen activator (rtPA) immobilized on the surface of magnetic nanoparticles induces thrombolysis by magnetic targeting. We asked whether i.v. delivery of protected rtPA in a thermosensitive magnetoliposome (TML@rtPA) may achieve target thrombolysis. PEGylated TML@rtPA was optimized and characterized; controlled release of rtPA was achieved by thermodynamic and magnetic manipulation in vitro. The lysis index of TML@rtPA incubated with blood at 43 °C vs. 37 °C was 53 ± 11% vs. 81 ± 3% in thromboelastograms, suggesting thermosensitive thrombolysis of TML@rtPA. In a rat embolic model with superfusion of 43 °C saline on a focal spot on the iliac artery with clot lodging, release of rtPA equivalent to 20% regular dose from TML@rtPA administered i.a. vs. i.v. significantly restored iliac blood flow 15 vs. 55 min after clot lodging, respectively. TML@rtPA with magnetic guiding and focal hyperthermia may be potentially amendable to target thrombolysis.

Keywords: Drug delivery; Liposomes; Magnetic nanoparticles; Recombinant tissue-type plasminogen activator; Thrombolysis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Administration, Intravenous
  • Animals
  • Biocompatible Materials / chemistry
  • Hyperthermia, Induced*
  • Liposomes
  • Magnetic Phenomena*
  • Male
  • Nanocomposites / chemistry
  • Nanocomposites / ultrastructure
  • Particle Size
  • Rats, Sprague-Dawley
  • Temperature
  • Thrombolytic Therapy*
  • Thrombosis
  • Tissue Plasminogen Activator / administration & dosage*

Substances

  • Biocompatible Materials
  • Liposomes
  • Tissue Plasminogen Activator